Issue 2/2011
Content (35 Articles)
Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies
Sihua Peng, Bingjian Lü, Wenjing Ruan, Yimin Zhu, Hongqiang Sheng, Maode Lai
Clinical significance of sentinel lymph node isolated tumour cells in breast cancer
Neill Patani, Kefah Mokbel
Management of radial sclerosing lesions of the breast diagnosed using percutaneous vacuum-assisted core needle biopsy: recommendations for excision based on seven years’ of experience at a single institution
Erika Resetkova, Marcia Edelweiss, Constance T. Albarracin, Wei T. Yang
Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer
Kirsten Vang Nielsen, Bent Ejlertsen, Sven Müller, Susanne Møller, Birgitte B. Rasmussen, Eva Balslev, Anne-Vibeke Lænkholm, Peer Christiansen, Henning T. Mouridsen
PALB2 analysis in BRCA2-like families
M. A. Adank, S. E. van Mil, J. J. P. Gille, Q. Waisfisz, H. Meijers-Heijboer
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer
François Bertucci, Nathalie Borie, Henri Roche, Thomas Bachelot, Jean-Marc Le Doussal, Gaëtan Macgrogan, Stéphane Debono, Agnès Martinec, Isabelle Treilleux, Pascal Finetti, Benjamin Esterni, Jean-Marc Extra, Jean Geneve, Fabienne Hermitte, Christian Chabannon, Jocelyne Jacquemier, Anne-Laure Martin, Michel Longy, Dominique Maraninchi, Vincent Fert, Daniel Birnbaum, Patrice Viens
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer
Yesim Gökmen-Polar, Rachel A. Toroni, Barbara A. Hocevar, Sunil Badve, Qianqian Zhao, Changyu Shen, Elizabeth Bruckheimer, Michael S. Kinch, Kathy D. Miller
The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells
Paul T. R. Thiruchelvam, Chun-Fui Lai, Hui Hua, Ross S. Thomas, Antoni Hurtado, William Hudson, Andrew R. Bayly, Fiona J. Kyle, Manikandan Periyasamy, Andrew Photiou, Alan C. Spivey, Eric A. Ortlund, Richard J. Whitby, Jason S. Carroll, R. Charles Coombes, Laki Buluwela, Simak Ali
Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells
Yuehan Wu, Xun Guo, Yekaterina Brandt, Helen J. Hathaway, Rebecca S. Hartley
Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer
Mohammed A. Aleskandarany, Emad A. Rakha, Mohamed A. Ahmed, Desmond G. Powe, Ian O. Ellis, Andrew R. Green
Estrogen receptor beta decreases survival of p53-defective cancer cells after DNA damage by impairing G2/M checkpoint signaling
Christoforos G. Thomas, Anders Strom, Karolina Lindberg, Jan-Ake Gustafsson
Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer
R. Coleman, E. Woodward, J. Brown, D. Cameron, R. Bell, D. Dodwell, M. Keane, M. Gil, C. Davies, R. Burkinshaw, S. J. Houston, R. J. Grieve, P. J. Barrett-Lee, H. Thorpe
Immediate reconstruction with implants in women with invasive breast cancer does not affect oncological safety in a matched cohort study
C. Eriksen, J. Frisell, M. Wickman, E. Lidbrink, K. Krawiec, K. Sandelin
Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial
Kerri M. Winters-Stone, Jessica Dobek, Lillian Nail, Jill A. Bennett, Michael C. Leo, Arpana Naik, Anna Schwartz
Erratum to: Strength training stops bone loss and builds muscle in postmenopausal breast cancer survivors: a randomized, controlled trial
Kerri M. Winters-Stone, Jessica Dobek, Lillian Nail, Jill A. Bennett, Michael C. Leo, Arpana Naik, Anna Schwartz
Accuracy of unidimensional and volumetric ultrasound measurements in predicting good pathological response to neoadjuvant chemotherapy in breast cancer patients
I. Gounaris, E. Provenzano, A. L. Vallier, L. Hiller, M. Iddawela, S. Hilborne, K. Taylor, P. Britton, H. M. Earl, R. Sinnatamby
Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry
Melinda L. Telli, Ellen T. Chang, Allison W. Kurian, Theresa H. M. Keegan, Laura A. McClure, Daphne Lichtensztajn, James M. Ford, Scarlett L. Gomez
Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women
E. Comen, L. Balistreri, M. Gönen, A. Dutra-Clarke, M. Fazio, J. Vijai, Z. Stadler, N. Kauff, T. Kirchhoff, C. Hudis, K. Offit, M. Robson
Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in Israel
Yael Laitman, Roni Tsipora Borsthein, Dominique Stoppa-Lyonnet, Efrat Dagan, Laurent Castera, Maud Goislard, Ruth Gershoni-Baruch, Hadassah Goldberg, Bella Kaufman, Noa Ben-Baruch, Jamal Zidan, Taiseer Maray, Lior Soussan-Gutman, Eitan Friedman
Periodontal disease may associate with breast cancer
Birgitta Söder, Maha Yakob, Jukka H. Meurman, Leif C. Andersson, Björn Klinge, Per-Östen Söder
Genetic variation in the androgen estrogen conversion pathway in relation to breast cancer prognosticators
Hatef Darabi, Kamila Czene, Sara Wedrén, Yuqing Li, Jianjun Liu, Per Hall, Keith Humphreys
Chemotherapy characteristics are important predictors of primary prophylactic CSF administration in older patients with breast cancer
Suja S. Rajan, Gary H. Lyman, William R. Carpenter, Sally C. Stearns
Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI)
Maria Pisu, Andres Azuero, Karen Meneses, Jeffrey Burkhardt, Patrick McNees
The role of polymorphisms in circadian pathway genes in breast tumorigenesis
Hongji Dai, Lina Zhang, Mingli Cao, Fengju Song, Hong Zheng, Xiaoling Zhu, Qingyi Wei, Wei Zhang, Kexin Chen
Improvement in self-reported physical health predicts longer survival among women with a history of breast cancer
Ruth E. Patterson, Nazmus Saquib, Loki Natarajan, Cheryl L. Rock, Barbara A. Parker, Cynthia A. Thomson, John P. Pierce
Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk
Rongxi Yang, Michelle Dick, Frederik Marme, Andreas Schneeweiss, Anne Langheinz, Kari Hemminki, Christian Sutter, Peter Bugert, Barbara Wappenschmidt, Raymonda Varon, Sarah Schott, Bernhard H. F. Weber, Dieter Niederacher, Norbert Arnold, Alfons Meindl, Claus R. Bartram, Rita K. Schmutzler, Heiko Müller, Volker Arndt, Hermann Brenner, Christof Sohn, Barbara Burwinkel
Circulating levels of inflammatory markers and mammographic density among postmenopausal women
Katherine W. Reeves, Joel L. Weissfeld, Francesmary Modugno, Brenda Diergaarde
Further studies based on better design are needed to explore the association of NPAS2 gene polymorphisms with breast cancer
Fang Wang, Yan-Feng Zou
VEGF 936C>T polymorphism and breast cancer risk: evidence needed further clarification
Liu Liu, Fu-Zhou Hua, Jia-Qing Cao, Pei-Qian Zhu
Soy consumption and breast cancer risk: four recent meta-analyses
Chun Zhang, Jian-Ping Li, Ping Zhou
Inspection of a deviation from Hardy–Weinberg equilibrium in familial breast cancer cases from a case–control study in a meta-analysis
Ke-Da Yu, Zhi-Ming Shao
Green tea consumption and breast cancer risk: three recent meta-analyses
Ping Zhou, Jian-Ping Li, Chun Zhang
Anthracyclines and trastuzumab; getting to the heart of the matter: when getting to the heart is the matter
Patrick G. Morris, Clifford A. Hudis
Estrogen receptor: is it predictive for response to cytotoxic as well as hormonal therapy?
Kathleen I. Pritchard
Can strategies targeting cleaved MUC1 overcome resistance to trastuzumab?
Kazuhiro Araki, Mark Pegram